Product
SPH7485
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
An Open, Multicenter, Dose-escalation, and Dose-expansion Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of SPH7485 Tablets in Patients With Advanced Solid Tumors.Status: Not yet recruiting, Estimated PCD: 2027-12-31